Base Partners

Base Partners is a Sao Paulo-based growth-stage VC writing $5M to $25M checks at Series B and growth stages, with a thesis built around bringing global insights to help Brazilian companies scale. The firm has been associated with companies like Stripe and Nubank as comparison points and influences, which signals the team’s pattern recognition around category-defining technology businesses with global ambitions. Within healthcare, the firm’s interest spans digital health and health IT software with credible enterprise GTM and applied AI capabilities, and the focus is on growth-stage opportunities rather than early-stage exploration. The geographic focus is Brazil with global ambitions for the strongest portfolio companies, and the partner team brings substantial international experience that bridges Brazilian operating realities with US institutional fundraising and exit pathways. The right founder profile is a CEO running a Series B-ready Brazilian healthtech company with proven commercial traction, defensible product moats, and a credible international expansion thesis. The wrong fit is an early-stage company; Base’s check size and stage focus are not designed for seed or Series A. The right entry path is through Sao Paulo growth-stage operator networks, through Series A leads who frequently syndicate growth rounds with Base, including firms like Kaszek, Monashees, and Canary, and through warm introductions from US-based investors who track Brazilian opportunities. When pitching, lead with the institutional-grade financial picture, the product moat, and the global expansion logic, then connect to the unit economics that work in Brazil and the operating discipline of the team. Avoid leading with a research narrative; Base wants to see commercial reality at scale. Caveats: Base’s relatively recent vintage means the track record of growth-stage exits is still being built, and the healthcare-specific operating expertise is generalist rather than specialist. Founders should layer clinical-domain advisors and specialist co-investors onto the cap table as the company scales internationally. Use Base when you are running a Series B-ready Brazilian healthtech company and need a globally networked growth-stage partner with US-bridging capacity.